Recent advances in antiangiogenic agents with VEGFR as target.
about
Extract of Pleurotus pulmonarius suppresses liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathwayBrucine suppresses colon cancer cells growth via mediating KDR signalling pathway.Coumestrol from the national cancer Institute's natural product library is a novel inhibitor of protein kinase CK2.A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylationEvolution of a New Class of VEGFR-2 Inhibitors from Scaffold Morphing and Redesign.
P2860
Recent advances in antiangiogenic agents with VEGFR as target.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Recent advances in antiangiogenic agents with VEGFR as target.
@en
Recent advances in antiangiogenic agents with VEGFR as target.
@nl
type
label
Recent advances in antiangiogenic agents with VEGFR as target.
@en
Recent advances in antiangiogenic agents with VEGFR as target.
@nl
prefLabel
Recent advances in antiangiogenic agents with VEGFR as target.
@en
Recent advances in antiangiogenic agents with VEGFR as target.
@nl
P2093
P1476
Recent advances in antiangiogenic agents with VEGFR as target.
@en
P2093
P304
P356
10.2174/138955711797068355
P577
2011-10-01T00:00:00Z